133 related articles for article (PubMed ID: 8400669)
1. Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.
Oka M; Mitsunaga H; Hazama S; Yoshino S; Suzuki T
Surg Today; 1993; 23(8):669-74. PubMed ID: 8400669
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of immunosuppressive acidic protein in patients with esophageal cancer.
Kogure M; Kashimura S; Matsuyama S; Ohtani S; Saze Z; Odashima Y; Saitoh T; Soeta N; Osuka F; Hoshino Y; Saito T; Terashima S; Terashima M; Gotoh M
Dis Esophagus; 2008; 21(3):214-9. PubMed ID: 18430101
[TBL] [Abstract][Full Text] [Related]
3. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
[TBL] [Abstract][Full Text] [Related]
4. Impaired NK response of cancer patients to IFN-alpha but not to IL-2: correlation with serum immunosuppressive acidic protein (IAP) and role of suppressor macrophage.
Aso H; Tamura K; Yoshie O; Nakamura T; Kikuchi S; Ishida N
Microbiol Immunol; 1992; 36(10):1087-97. PubMed ID: 1479963
[TBL] [Abstract][Full Text] [Related]
5. The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.
Yanagawa E; Toge T; Sawamura A; Kegoya Y; Baba N; Hattori T
Jpn J Surg; 1988 Nov; 18(6):660-7. PubMed ID: 2977625
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.
Szkaradkiewicz A; Karpiński TM; Drews M; Borejsza-Wysocki M; Majewski P; Andrzejewska E
J Biomed Biotechnol; 2010; 2010():901564. PubMed ID: 20445748
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
Moritani Y
Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
[TBL] [Abstract][Full Text] [Related]
9. The clinical status and histopathological factors affecting natural killer cells of peripheral blood lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T
J Clin Lab Immunol; 1991 Jul; 35(3):97-108. PubMed ID: 1668768
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive acidic protein (IAP) in gastric cancer patients.
Shimizu N; Yamane T; Karino T; Hamazoe R; Osaki Y; Kanayama H; Maeta M; Koga S
Jpn J Surg; 1983 Jul; 13(4):312-6. PubMed ID: 6645122
[TBL] [Abstract][Full Text] [Related]
11. [Study of PyNPase activity in patients with gastric cancer--the association with preoperative IAP values].
Kirita T; Hamano K; Mabuchi G; Seshimo A; Kawase A; Miyashita M; Inada N
Gan To Kagaku Ryoho; 1995 Mar; 22(4):509-14. PubMed ID: 7887642
[TBL] [Abstract][Full Text] [Related]
12. [Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients].
Zeze K; Saito T; Kobayashi M
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):22-33. PubMed ID: 2704363
[TBL] [Abstract][Full Text] [Related]
13. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.
Takeuchi H; Maehara Y; Tokunaga E; Koga T; Kakeji Y; Sugimachi K
Am J Gastroenterol; 2001 Feb; 96(2):574-8. PubMed ID: 11232710
[TBL] [Abstract][Full Text] [Related]
15. Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients.
Ikuta S; Miki C; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Kusunoki M
Dig Surg; 2003; 20(6):532-8. PubMed ID: 14534376
[TBL] [Abstract][Full Text] [Related]
16. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S; Sakamoto J; Teramukai S; Kunieda K; Sugiyama Y; Ohashi Y; Nakazato H
Surg Today; 1999; 29(6):504-10. PubMed ID: 10385364
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Sakamoto J; Teramukai S; Koike A; Saji S; Ohashi Y; Nakazato H
Cancer; 1996 Jun; 77(11):2206-12. PubMed ID: 8635085
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.
Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1987 Aug; 22(4):428-34. PubMed ID: 3117611
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
